Special Communication

The Future of Cervical Cancer Screening Is Digital

Cleveland Clinic Laboratories is leveraging digital pathology and artificial intelligence to advance Pap test interpretation and cervical cancer screening.

Our cytopathology team has transitioned to a fully digital workflow and integrated AI-assisted prescreening into daily practice following validation of nearly 1,800 cases. The technology helps identify areas of interest and supports our cytopathologists during case review—augmenting their expertise rather than replacing it.

This combination of advanced technology and specialized clinical expertise represents an important step forward in cytopathology and the continued evolution of laboratory medicine.

See Innovation in Action

Watch the video to learn how Cleveland Clinic Laboratories is using digital pathology and AI to support the next generation of cervical cancer screening.